562 related articles for article (PubMed ID: 25970242)
21. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
22. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
[TBL] [Abstract][Full Text] [Related]
23. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
24. Identification of MYC intron 2 regions that modulate expression.
Tompkins VS; Xue Z; Peterson JM; Rouse WB; O'Leary CA; Moss WN
PLoS One; 2024; 19(1):e0296889. PubMed ID: 38236931
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
Iwai K; Yaguchi M; Nishimura K; Yamamoto Y; Tamura T; Nakata D; Dairiki R; Kawakita Y; Mizojiri R; Ito Y; Asano M; Maezaki H; Nakayama Y; Kaishima M; Hayashi K; Teratani M; Miyakawa S; Iwatani M; Miyamoto M; Klein MG; Lane W; Snell G; Tjhen R; He X; Pulukuri S; Nomura T
EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29769258
[TBL] [Abstract][Full Text] [Related]
26. The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.
Jacob AG; Singh RK; Mohammad F; Bebee TW; Chandler DS
J Biol Chem; 2014 Jun; 289(25):17350-64. PubMed ID: 24798327
[TBL] [Abstract][Full Text] [Related]
27. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
[TBL] [Abstract][Full Text] [Related]
28. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
[TBL] [Abstract][Full Text] [Related]
29. Splicing inhibition of U2AF65 leads to alternative exon skipping.
Cho S; Moon H; Loh TJ; Jang HN; Liu Y; Zhou J; Ohn T; Zheng X; Shen H
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9926-31. PubMed ID: 26216990
[TBL] [Abstract][Full Text] [Related]
30. A spliceosomal intron binding protein, IBP160, links position-dependent assembly of intron-encoded box C/D snoRNP to pre-mRNA splicing.
Hirose T; Ideue T; Nagai M; Hagiwara M; Shu MD; Steitz JA
Mol Cell; 2006 Sep; 23(5):673-84. PubMed ID: 16949364
[TBL] [Abstract][Full Text] [Related]
31. New components of the spliced leader RNP required for nematode trans-splicing.
Denker JA; Zuckerman DM; Maroney PA; Nilsen TW
Nature; 2002 Jun; 417(6889):667-70. PubMed ID: 12050671
[TBL] [Abstract][Full Text] [Related]
32. Pre-mRNA splicing: a complex picture in higher definition.
Schellenberg MJ; Ritchie DB; MacMillan AM
Trends Biochem Sci; 2008 Jun; 33(6):243-6. PubMed ID: 18472266
[TBL] [Abstract][Full Text] [Related]
33. Regulation of mammalian pre-mRNA splicing.
Hui J
Sci China C Life Sci; 2009 Mar; 52(3):253-60. PubMed ID: 19294350
[TBL] [Abstract][Full Text] [Related]
34. A two-step mechanism for 5' and 3' splice-site pairing.
Chiara MD; Reed R
Nature; 1995 Jun; 375(6531):510-3. PubMed ID: 7777062
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
Tei S; Ishii HT; Mitsuhashi H; Ishiura S
Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
[TBL] [Abstract][Full Text] [Related]
36. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
37. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
38. Plant pre-mRNA splicing and splicing components.
Brown JW; Simpson CG; Simpson GG; Turnbull-Ross AD; Clark GP
Philos Trans R Soc Lond B Biol Sci; 1993 Nov; 342(1301):217-24. PubMed ID: 8115450
[TBL] [Abstract][Full Text] [Related]
39. Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1.
Webb E; Barri G; Cory S; Adams JM
Mol Biol Med; 1989 Dec; 6(6):475-80. PubMed ID: 2699507
[TBL] [Abstract][Full Text] [Related]
40. Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon-exon junctions.
Le Hir H; Moore MJ; Maquat LE
Genes Dev; 2000 May; 14(9):1098-108. PubMed ID: 10809668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
